Literature DB >> 21468583

The prevalence of celiac disease in patients with irritable bowel syndrome.

M El-Salhy1, B Lomholt-Beck, D Gundersen.   

Abstract

The diagnosis of irritable bowel syndrome (IBS) is based on symptom assessment such as the Rome III criteria. It is sometimes difficult to clinically distinguish IBS from adult-onset celiac disease (CD). Individuals with CD presenting with relatively vague abdominal symptoms are at risk of been dismissed as having IBS. This study aimed to investigate the prevalence of patients with CD among those that fulfill the Rome III criteria for IBS from among patients referred to the gastroenterology section of our hospital over the last 5 years. The study included a total of 968 patients with an average age of 32 years (range 18-59 years). Females constituted 95% of all patients. Duodenal biopsies were obtained during standard gastroscopy. Sections from these biopsies were stained with haematoxylin and eosin and immunostained for human leucocytes CD45 using the avidin-biotin complex (ABC) method. The sections were then histopathologically examined. Four patients had CD: one with Marsh type 3b, and 3 with Marsh type 1. All four of these patients were positive for tissue transglutminase antibodies (anti-t-TG) IgA and were females aged 24, 20, 36 and 38 years. These 4 patients fulfilled the Rome III criteria for the sub-type IBS-diarrhea. This amounts to a prevalence of 0.4% of CD in IBS patients. The present findings support the notion that IBS patients should be routinely examined for CD. This applies to all subtypes of IBS.

Entities:  

Mesh:

Year:  2011        PMID: 21468583     DOI: 10.3892/mmr.2011.466

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  14 in total

1.  Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea.

Authors:  Banny S Wong; Michael Camilleri; Paula J Carlson; Suwebatu Odunsi-Shiyanbade; Sanna McKinzie; Irene Busciglio; Duane Burton; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2012-01-21       Impact factor: 3.199

2.  The prevalence of celiac disease among patients with nonconstipated irritable bowel syndrome is similar to controls.

Authors:  Brooks D Cash; Joel H Rubenstein; Patrick E Young; Andrew Gentry; Borko Nojkov; Dong Lee; A Hirsohi Andrews; Richard Dobhan; William D Chey
Journal:  Gastroenterology       Date:  2011-07-14       Impact factor: 22.682

3.  Irritable bowel syndrome: diagnosis and pathogenesis.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

4.  Human leukocyte antigen DQ2/8 prevalence in non-celiac patients with gastrointestinal diseases.

Authors:  Daniel DiGiacomo; Antonella Santonicola; Fabiana Zingone; Edoardo Troncone; Maria Cristina Caria; Patrizia Borgheresi; Gianpaolo Parrilli; Carolina Ciacci
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

5.  Irritable bowel syndrome: the role of food in pathogenesis and management.

Authors:  Paula A Hayes; Marianne H Fraher; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03

Review 6.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

7.  Frequency of celiac disease in adult patients with typical or atypical malabsorption symptoms in isfahan, iran.

Authors:  Mohammad Hassan Emami; Soheila Kouhestani; Somayeh Karimi; Abdolmahdi Baghaei; Mohsen Janghorbani; Nahid Jamali; Ali Gholamrezaei
Journal:  Gastroenterol Res Pract       Date:  2012-04-01       Impact factor: 2.260

8.  Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Gastroenterol Res Pract       Date:  2014-06-16       Impact factor: 2.260

Review 9.  The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Odd Helge Gilja; Trygve Hausken
Journal:  Nutr J       Date:  2015-09-07       Impact factor: 3.271

Review 10.  Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review).

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan G Hatlebakk; Trygve Hausken
Journal:  Int J Mol Med       Date:  2014-06-17       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.